Production of the monoclonal antibody Trastuzumab in Komagataella phaffii (Pichia pastoris) for breast cancer treatment

Trastuzumab is a monoclonal antibody used for targeted breast cancer treatment. The production of the monoclonal antibody, trastuzumab, by the yeast Komagataella phaffii (Pichia pastoris) production system is being studied by INRAE - TWB. The expression of the genes coding heavy and light chain of the antibody is controlled by two ethanol inducible promoters.

Programme: Bioindustry 4.0

Public web page: Not specified

Powered by
 (v.1.17.2)
About IBISBA | About IBISBA Knowledge Hub | Funding and Programmes | Credits | Terms & Conditions
Copyright © 2008 - 2025 The University of Manchester and HITS gGmbH
IBISBA is a pan-European research infrastructure currently funded through multiple EU projects: IBISBA 1.0 (H2020 grant agreement No. 730976), PREP-IBISBA (H2020 grant agreement No. 871118) and the follow-on project IBISBA-DIALS (grant agreement No. 101131085) and BIOINDUSTRY 4.0 (Grant agreement No. 101094287). Registering data or other knowledge assets on this platform is the sole responsibility of Users. IBISBA cannot be held responsible for misuse or misappropriation of data and assets belonging to a Third Party.